OBJECTIVES: Isocyanate chemicals essential for polyurethane production are widely used industrially, and are increasingly found in consumer products. Asthma and other adverse health effects of isocyanates are well-documented and exposure surveillance is crucial to disease prevention. Hexamethylene diisocyanate (HDI)-specific serum immunoglobulin G (IgG) was evaluated as an exposure biomarker among workers at a US Air Force Air Logistics Center, which includes a large aircraft maintenance facility. METHODS: HDI-specific IgG (HDI-IgG) titers in serum samples (n = 74) were measured using an enzyme-linked immunosorbent assay based upon the biuret form of HDI conjugated to human albumin. Information on personal protective equipment (PPE), work location/tasks, smoking, asthma history, basic demographics, and HDI skin exposure was obtained through questionnaire. RESULTS: HDI-specific serum IgG levels were elevated in n = 17 (23%) of the workers studied. The prevalence and/or end-titer of the HDI-IgG was significantly (P < 0.05) associated with specific job titles, self-reported skin exposure, night-shift work, and respirator use, but not atopy, asthma, or other demographic information. The highest titers were localized to specific worksites (C-130 painting), while other worksites (generator painting) had no or few workers with detectable HDI-IgG. CONCLUSIONS: HDI-specific immune responses (IgG) provide a practical biomarker to aid in exposure surveillance and ongoing industrial hygiene efforts. The strategy may supplement current air sampling approaches, which do not assess exposures via skin, or variability in PPE use or effectiveness. The approach may also be applicable to evaluating isocyanate exposures in other settings, and may extend to other chemical allergens.
OBJECTIVES:Isocyanate chemicals essential for polyurethane production are widely used industrially, and are increasingly found in consumer products. Asthma and other adverse health effects of isocyanates are well-documented and exposure surveillance is crucial to disease prevention. Hexamethylene diisocyanate (HDI)-specific serum immunoglobulin G (IgG) was evaluated as an exposure biomarker among workers at a US Air Force Air Logistics Center, which includes a large aircraft maintenance facility. METHODS: HDI-specific IgG (HDI-IgG) titers in serum samples (n = 74) were measured using an enzyme-linked immunosorbent assay based upon the biuret form of HDI conjugated to human albumin. Information on personal protective equipment (PPE), work location/tasks, smoking, asthma history, basic demographics, and HDI skin exposure was obtained through questionnaire. RESULTS: HDI-specific serum IgG levels were elevated in n = 17 (23%) of the workers studied. The prevalence and/or end-titer of the HDI-IgG was significantly (P < 0.05) associated with specific job titles, self-reported skin exposure, night-shift work, and respirator use, but not atopy, asthma, or other demographic information. The highest titers were localized to specific worksites (C-130 painting), while other worksites (generator painting) had no or few workers with detectable HDI-IgG. CONCLUSIONS: HDI-specific immune responses (IgG) provide a practical biomarker to aid in exposure surveillance and ongoing industrial hygiene efforts. The strategy may supplement current air sampling approaches, which do not assess exposures via skin, or variability in PPE use or effectiveness. The approach may also be applicable to evaluating isocyanate exposures in other settings, and may extend to other chemical allergens.
Authors: Robert P Streicher; Christopher M Reh; Rosa Key-Schwartz; Paul C Schlecht; Mary Ellen Cassinelli; Paula Fey O'Connor Journal: Appl Occup Environ Hyg Date: 2002-03
Authors: Anjoeka Pronk; Liesbeth Preller; Monika Raulf-Heimsoth; Irene C L Jonkers; Jan-Willem Lammers; Inge M Wouters; Gert Doekes; Adam V Wisnewski; Dick Heederik Journal: Am J Respir Crit Care Med Date: 2007-07-26 Impact factor: 21.405
Authors: Jeroen A J Vanoirbeek; Maciej Tarkowski; Jan L Ceuppens; Erik K Verbeken; Benoit Nemery; Peter H M Hoet Journal: Toxicol Sci Date: 2004-05-05 Impact factor: 4.849
Authors: H L Francis; J Mann; R L Colebunders; L Ndongala; D Mavunza-Mpaka; K Bila; J Curran; P Piot; T C Quinn Journal: Am J Trop Med Hyg Date: 1988-05 Impact factor: 2.345
Authors: Daniel Lefkowitz; Elise Pechter; Kathleen Fitzsimmons; Margaret Lumia; Alicia C Stephens; Letitia Davis; Jennifer Flattery; Justine Weinberg; Robert J Harrison; Mary Jo Reilly; Margaret S Filios; Gretchen E White; Kenneth D Rosenman Journal: Am J Ind Med Date: 2015-09-09 Impact factor: 2.214
Authors: James E Lockey; Carrie A Redlich; Robert Streicher; Andrea Pfahles-Hutchens; Pertti Bert J Hakkinen; Gary L Ellison; Philip Harber; Mark Utell; John Holland; Andrew Comai; Marc White Journal: J Occup Environ Med Date: 2015-01 Impact factor: 2.162
Authors: Adam V Wisnewski; Jean Kanyo; Jennifer Asher; James A Goodrich; Grace Barnett; Lyn Patrylak; Jian Liu; Carrie A Redlich; Ala F Nassar Journal: Xenobiotica Date: 2017-06-01 Impact factor: 1.908
Authors: Morgen Mhike; Justin M Hettick; Itai Chipinda; Brandon F Law; Toni A Bledsoe; Angela R Lemons; Ajay P Nayak; Brett J Green; Donald H Beezhold; Reuben H Simoyi; Paul D Siegel Journal: J Immunol Methods Date: 2016-02-04 Impact factor: 2.303